Elizabeth E. Gillespie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Elizabeth E. Gillespie has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Rhonda L. Stuart
South East Public Health Unit, Monash Health, Melbourne, Australia
5 shared publications Despina Kotsanas
Southern Health Infectious Diseases Unit, Monash Medical Centre, Southern Health, Melbourne, Victoria, Australia
2 shared publicationsAnne Rodrigues
1 shared publicationCarmel Scott
1 shared publicationCarryn Kaye
1 shared publicationFiona J. Ten Berk de Boer
Dandenong Hospital, Dandenong, VIC.
1 shared publication
Latest Publications
- 1 October 2016
- Vol. 24 (4) , 26-8
USING ADENOSINETRIPHOSPHATE BIOLUMINESCENCE TO VALIDATE DECONTAMINATION FOR DUODENOSCOPES.
Reports of outbreaks involving Carbapenemase resistant Enterobacteriaceae have been associated with gastrointestinal endoscopy. We used Adenosinetriphosphate (ATP) bioluminescence to demonstrate cleanliness prior to Endoscopic Retrograde Cholangiopancreatography (ERCP). We compared ATP testing with microbiological monitoring for 40 duodenoscopes. ATP testing of duodenoscopes prior to ERCP procedures provided a timely marker of safety and quality.
- 1 October 2016
- Vol. 24 (4) , 26-8
USING ADENOSINETRIPHOSPHATE BIOLUMINESCENCE TO VALIDATE DECONTAMINATION FOR DUODENOSCOPES.
Reports of outbreaks involving Carbapenemase resistant Enterobacteriaceae have been associated with gastrointestinal endoscopy. We used Adenosinetriphosphate (ATP) bioluminescence to demonstrate cleanliness prior to Endoscopic Retrograde Cholangiopancreatography (ERCP). We compared ATP testing with microbiological monitoring for 40 duodenoscopes. ATP testing of duodenoscopes prior to ERCP procedures provided a timely marker of safety and quality.
- 1 April 2013
- Published by Elsevier in American Journal of Infection Control
- Vol. 41 (4) , 365-367
Improving antibiotic stewardship by involving nurses
- 1 April 2013
- Published by Elsevier in American Journal of Infection Control
- Vol. 41 (4) , 365-367
Improving antibiotic stewardship by involving nurses
- 1 June 2012
- Published by Elsevier in American Journal of Infection Control
- Vol. 40 (5) , 477-478
Pilot study to measure cleaning effectiveness in health care
- 1 June 2012
- Published by Elsevier in American Journal of Infection Control
- Vol. 40 (5) , 477-478
Pilot study to measure cleaning effectiveness in health care
- 16 July 2008
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 23 (7pt1) , 1069-1074
Microbiological monitoring of endoscopes: 5‐year review
Periodic microbiological monitoring of endoscopes is a recommendation of the Gastroenterological Society of Australia (GENSA). The aim of monitoring has been to provide quality assurance of the cleaning and disinfection of endoscopes; however, there is controversy regarding its frequency. This lack of consensus stimulated a review of the experience within our health service. At Southern Health, routine microbiological sampling has involved 4‐weekly monitoring of bronchoscopes, duodenoscopes and automated flexible endoscope reprocessors (AFER), and 3‐monthly monitoring of all other gastrointestinal endoscopes. Records of testing were reviewed from 1 January 2002 until 31 December 2006. A literature review was conducted, cost analysis performed and positive cultures investigated. There were 2374 screening tests performed during the 5‐year period, including 287 AFER, 631 bronchoscopes for mycobacteria and 1456 endoscope bacterial screens. There were no positive results of the AFER or bronchoscopes for mycobacteria. Of the 1456 endoscopic bacterial samples, six were positive; however, retesting resulted in no growth. The overall cost of tests performed and cost in time for nursing staff to collect the samples was estimated at $AUD 100 400. Periodic monitoring of endoscopes is both time‐consuming and costly. Our review demonstrates that AFER (Soluscope) perform well in cleaning endoscopes. Based on our 5‐year experience, assurance of quality for endoscopic use could be achieved through process control as opposed to product control. Maintenance of endoscopes and AFER should be in accordance with the manufacturer's instructions and microbiological testing performed on commissioning, annually and following repair. Initial prompt manual leak testing and manual cleaning followed by mechanical leak testing, cleaning and disinfection should be the minimum standard in reprocessing of endoscopes.
- 16 July 2008
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 23 (7pt1) , 1069-1074
Microbiological monitoring of endoscopes: 5‐year review
Periodic microbiological monitoring of endoscopes is a recommendation of the Gastroenterological Society of Australia (GENSA). The aim of monitoring has been to provide quality assurance of the cleaning and disinfection of endoscopes; however, there is controversy regarding its frequency. This lack of consensus stimulated a review of the experience within our health service. At Southern Health, routine microbiological sampling has involved 4‐weekly monitoring of bronchoscopes, duodenoscopes and automated flexible endoscope reprocessors (AFER), and 3‐monthly monitoring of all other gastrointestinal endoscopes. Records of testing were reviewed from 1 January 2002 until 31 December 2006. A literature review was conducted, cost analysis performed and positive cultures investigated. There were 2374 screening tests performed during the 5‐year period, including 287 AFER, 631 bronchoscopes for mycobacteria and 1456 endoscope bacterial screens. There were no positive results of the AFER or bronchoscopes for mycobacteria. Of the 1456 endoscopic bacterial samples, six were positive; however, retesting resulted in no growth. The overall cost of tests performed and cost in time for nursing staff to collect the samples was estimated at $AUD 100 400. Periodic monitoring of endoscopes is both time‐consuming and costly. Our review demonstrates that AFER (Soluscope) perform well in cleaning endoscopes. Based on our 5‐year experience, assurance of quality for endoscopic use could be achieved through process control as opposed to product control. Maintenance of endoscopes and AFER should be in accordance with the manufacturer's instructions and microbiological testing performed on commissioning, annually and following repair. Initial prompt manual leak testing and manual cleaning followed by mechanical leak testing, cleaning and disinfection should be the minimum standard in reprocessing of endoscopes.
- Open Access
- 1 June 2007
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 9 (2) , 161-165
A sustained reduction in the transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit
- 1 June 2007
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 9 (2) , 161-165
Open AccessA sustained reduction in the transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit
- 1 January 2007
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 35 (3) , 227-31
Serratia marcescens bacteremia – an indicator for outbreak management and heightened surveillance
Colonization of neonatal intensive care units by Serratia marcescens is associated with clinical outbreaks. We report the management of an outbreak in a newborn services unit (NBS), in 2004, of a strain of S. marcescens that was present in the unit from 1994. Over the 10-year period, increases in clinical isolates demonstrated three epidemic curves, each spanning 3-4 years and each involving positive blood cultures. In 2004, clinical isolates of S. marcescens bacteremia prompted an investigation. Control measures including screening, creation of a separate unit, use of contact precautions, education, environmental sampling, strategies to reduce overcrowding, surveillance and molecular epidemiological techniques were implemented. In total, 99 babies were either colonized or infected with S. marcescens between December 2003 and December 2005. Isolates were tested with ribotyping identifying one main endemic strain. No environmental source was found, however, the outbreak terminated following adherence to infection control principles. Epidemiological information, structural and practice changes were used to prevent transmission and control the outbreak.
- 1 January 2007
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 35 (3) , 227-31
Serratia marcescens bacteremia – an indicator for outbreak management and heightened surveillance
Colonization of neonatal intensive care units by Serratia marcescens is associated with clinical outbreaks. We report the management of an outbreak in a newborn services unit (NBS), in 2004, of a strain of S. marcescens that was present in the unit from 1994. Over the 10-year period, increases in clinical isolates demonstrated three epidemic curves, each spanning 3-4 years and each involving positive blood cultures. In 2004, clinical isolates of S. marcescens bacteremia prompted an investigation. Control measures including screening, creation of a separate unit, use of contact precautions, education, environmental sampling, strategies to reduce overcrowding, surveillance and molecular epidemiological techniques were implemented. In total, 99 babies were either colonized or infected with S. marcescens between December 2003 and December 2005. Isolates were tested with ribotyping identifying one main endemic strain. No environmental source was found, however, the outbreak terminated following adherence to infection control principles. Epidemiological information, structural and practice changes were used to prevent transmission and control the outbreak.